Back to News
Market Impact: 0.05

NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine

Source: globenewswire.com

Corporate Earnings
NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine

The company said it will issue a press release before market open, followed by a conference call at 8:30 a.m. ET. The notice provides no financial results or other substantive company information.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

More News

From AllMind Research

Browse all research